Infinant Health, Inc.
Molecular diagnostic platform for early detection of diseases in infants using biomarkers
- Sector
- Medtech
- Headquarters
- Sacramento, CA
- Latest Form D
- $39.2M, Jun 2026
- Total capital
- $39.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $39.2M
- 1 Form D · last Jun 2026
- 5 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 19 pending · first 2025
- Rank in peer group#23 of 73
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$39.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 73 peers
Line = medianMedtech · Platform
- Granted patents#23 · top 32%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Amanda Birdsey-BensonDirectorNamed in SEC Form D filings
- Katharine KnobilDirectorNamed in SEC Form D filings
- Laura StoppelDirectorNamed in SEC Form D filings
- Michael JohnsonExecutive Officer, DirectorNamed in SEC Form D filings
- Mike LiangDirectorNamed in SEC Form D filings
- Patrick EnrightDirectorNamed in SEC Form D filings
Show all 7 people
- Roger WyseDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 21- GrantedCompositions And Method Of Use For H5 Competent Bifidobacterium Longum Subsp. InfantisUSPTOUS 12,584,101
- PendingCompositions And Method Of Use For H5 Competent Bifidobacterium Longum Subsp. InfantisUSPTOApplication 19317997
- PendingMethod For Facilitating Maturation Of The Mammalian Immune SystemUSPTOApplication 19262777
Show all 21 patent records
- Compositions And Method Of Use For H5 Competent Bifidobacterium Longum Subsp. InfantisMar 24, 2026 · US 12,584,101Granted
- Compositions And Method Of Use For H5 Competent Bifidobacterium Longum Subsp. InfantisDec 25, 2025 · Application 19317997Pending
- Method For Facilitating Maturation Of The Mammalian Immune SystemOct 30, 2025 · Application 19262777Pending
- Transient Commensal Microorganism For Improving Gut HealthSep 4, 2025 · Application 18917304Pending
- Method For Facilitating Maturation Of The Mammalian Immune SystemAug 26, 2025 · US 12,397,025Granted
- Microbiome Mediated Induction Of Immune Tolerance And Resolution Of InflammationJan 25, 2024 · Application 18018178Pending
- NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUMAug 11, 2022 · Application 17630018Pending
- Diagnosis And Treatment Of Dysbiosis-associated With NecMar 17, 2022 · Application 17420596Pending
- Compostions And Method Of Use For H5 Competent Bifidobacterium Longum Subsp. InfantisJan 13, 2022 · Application 17059928Pending
- Compositions And Methods To Promote Host Defense And Stimulate, Expand, And/or Reset T Cell RepertoiresOct 7, 2021 · Application 15733936Pending
- Novel Oligosaccharides For Use In Prebiotic ApplicationsJun 3, 2021 · Application 17254495Pending
- Metabolomic Revision Of Mammalian InfantsMar 11, 2021 · Application 16646687Pending
- Activated Bifidobacteria And Methods Of Use ThereofDec 24, 2020 · Application 16895641Pending
- Method For Determining Dysbiosis In The Intestinal MicrobiomeDec 10, 2020 · Application 16959595Pending
- Activation Of Conditionally-expressed Oligosaccharide Pathways During Fermentation Of Probiotic StrainsNov 5, 2020 · Application 16962627Pending
- Transient Commensal Microorganism for Improving Gut HealthFeb 13, 2020 · Application 16084154Pending
- Food Compositions for WeaningMar 7, 2019 · Application 16084207Pending
- Methods For Treating Enteric InjuryApplication PCTUS2024032607Pending
- Methods For Treating Enteric InjuryApplication 63471087Pending
- Methods For Treating Enteric InjuryApplication 19490106Pending
- Probiotic Compositions For Weaning InfantsApplication 18286810Pending
Related companies, and why
- SPINAL SINGULARITY, INC.Similar federal contract value in Medtech · null in contracts
- VITAE INDUSTRIES, INC.Similar federal contract value in Medtech · null in contracts
- BAMF Health Parent, Inc.Similar federal contract value in Medtech · null in contracts
- Valius Health, Inc.Similar federal contract value in Medtech · null in contracts
- VB Spine Holdings LLCSimilar federal contract value in Medtech · null in contracts
- Centile Bioscience Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .